Altaris Acquires Minaris Regenerative Medicine from Resonac
September 23, 2024
Altaris, LLC has acquired Minaris Regenerative Medicine from Resonac Corporation, making Minaris a wholly owned portfolio company of Altaris. Minaris is a cell therapy CDMO with six facilities across the United States, Germany and Japan and more than 500 employees; the deal advances Altaris' strategic initiative to build capabilities in cell and gene therapy manufacturing.
- Buyers
- Altaris, LLC
- Targets
- Minaris Regenerative Medicine
- Sellers
- Resonac Corporation, Resonac Holdings Corporation
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.